CN1925786A - Methods and devices for non-invasively measuring quantitative information of substances in living organisms - Google Patents
Methods and devices for non-invasively measuring quantitative information of substances in living organisms Download PDFInfo
- Publication number
- CN1925786A CN1925786A CNA2005800069260A CN200580006926A CN1925786A CN 1925786 A CN1925786 A CN 1925786A CN A2005800069260 A CNA2005800069260 A CN A2005800069260A CN 200580006926 A CN200580006926 A CN 200580006926A CN 1925786 A CN1925786 A CN 1925786A
- Authority
- CN
- China
- Prior art keywords
- signal
- electrical signature
- impedance
- electrode
- characteristic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0537—Measuring body composition by impedance, e.g. tissue hydration or fat content
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Disclosed are systems and methods of determining the amount of a substance in a living organism. In one embodiment, the method comprises: applying an electrical signature signal to the living organism, wherein the electrical signature signal corresponds to a predetermined amount of the substance; measuring the response of the living organism to the applied signature signal; and determining whether an elevated response has resulted from applying the electrical signature signal, if so, then determining the amount of the substance in the living organism from the predetermined amount of the substance.
Description
Mutual reference with related application
It number is 60/550 that the application requires the U.S. Provisional Patent Application of " method and apparatus that is used for the quantitative information of non-invasively measuring live body material " by name submitted on March 6th, 2004, the rights and interests of 913 date of application, disclosing of this application is contained in this, with for referencial use.
Technical field
Relate generally to medical measuring device of the present invention especially relates to the method and apparatus of the quantitative information that is used for non-invasively measuring live body material.
Background technology
Live body and functional system thereof are the sources of atomic light current magnetic oscillation in the wide frequency spectrum.The therapeutic process of several integral body utilizes this principle.These therapeutic processes utilize special very careful oscillation information, and are commonly called " bioresonance therapy ".
Term bioresonance therapy (" BRT ") is to be created for " using patient's oneself electromagnetic oscillation treatment " in 1987 by Brugemann academy.This principle can be traced back to doctor F.Morrell, and he is in 1977 uses that proposed its viewpoint first.Morrell doctor supposes that all diseases and its prerequisite are all with electromagnetic oscillation or caused by electromagnetic oscillation.According to Morrell doctor's supposition, do not exist in the health or health around do not have the pathological phenomenon of the vibration of pathology.
The electromagnetic oscillation of pathology enlivens with the vibration of the health of each patient body.Because patient's oneself vibration or signal are electromagnetic in essence, therefore by using electrode and electromagnetic measurement device can detect them.Use is called as the thing of separator, by wave filter can filtering practically identical harmony in all human bodies vibration.May then can not catch by filtered device by the interfering frequency that pathogen causes.Therefore, separator only with the frequency resonance of harmony.Like this, frequency humorous frequency on good terms that may separate harmonious.
Diabetes are diseases of a kind of life threatening, and it has influenced estimates 20,000,000 Americans, and this is 50% people and do not know to fall ill wherein.Up-to-date statistical estimate shows that the whole world has 100,002,005 million peoples to be suffered from diabetes by diagnosis approximately, and by 2010, this numeral was expected to rise to 200,012,000.The earlier detection of diabetes is accessible, to allow those people that are subjected to disease infringement to live longlyer and more healthy.The supervision of blood sugar level and tracking provide valuable information, to help control patient's diabetes.Regularly use the diabetes patient of insulin to need every day to check glucose level three times or more times.The process of this monitor glucose level allows the doctor to grasp instant and primary information in the healing that detects disease.
During nineteen seventies, invented instrument based on the monitor glucose level of chemical test sheet, this chemical test sheet can react with the blood of extracting out.Now, be useful on the electronic machine of the complexity of determining blood sugar level; Yet these instruments still use invasive technology to extract blood sample out from patient.Yet this technology is invasive, inconvenient, and allow the people feel pain sometimes.Wish to use electromagnetic oscillation to determine the in vivo quantity of certain material, blood glucose for example, rather than use invasive technology, for example blood count.In addition, use the vibration of different material to determine that in vivo the level of any material also will be useful.
Therefore, needed is can be usually by using electromagnetic oscillation, test substances non-invasively is for example in the blood or the method for the intravital glucose level of body and/or device.
Summary of the invention
Above-mentioned need the realization by various embodiments of the present invention.Therefore, in one embodiment, a kind of method and system that is used for non-invasively measuring live body levels of substance is provided, and described method comprises: measure the electromotive force between the point on the different passages through which vital energy circulates of vegetalitas system, perhaps measure the electromotive force between the difference on the organism skin; Described measured value is stored as reference point; Apply a plurality of low-current electrical signal, wherein each signal comes from the signal of telecommunication of extraction of the concentration known of described material corresponding to the front, to determine described reference point and poor to the maximum between the response of the described signal of telecommunication, then by using the table that described maximum is poor and the front is determined, determine the quantity of described in vivo described material, wherein said table is related with described maximum difference with the described quantity of described material.
On the other hand, disclose and determined that the in vivo method of material, described method comprise that applying electrical signature signal (signature signal) arrives described live body, wherein said electrical signature signal is corresponding to the predetermined quantity of described material; Measure of the response of described live body to the described characteristic signal that applies; And whether the response that determine to increase produce by applying described electronic signal (electrical signature), if then determine the quantity of described in vivo described material from the predetermined quantity of described material.
On the other hand, the detection of described " health response " is according to for being applied to the same substance signal waveform on the health between 2 (signature wave) on the described skin, monitors the conductivity variations of generation continuously and the convergence level of time relation curve.
On the other hand, be useful on the process that the similar frequency with precognition concentration of glucose in the self-oscillating frequency of different glucose molecule concentration in the blood of human body and the reference solution is complementary.As the result of this resonance or " glucose resonance (GlucoResonance) ", the electromotive force (" acupuncture point level " (" aculevel ")) on the human body between two predefined acupuncture points alters a great deal.The acupuncture point level that described variation is represented to measure and do not have poor between the acupuncture point level of glucose resonance with glucose resonance.
An internal database that has the self-oscillating frequency that the biological solutions of different glucose levels extracts from hundreds of is used in aspect, and wherein glucose level comprises the blood sugar level scope from 10mg/dl to 600mg/dl.In order to test the glucose in the blood,, can on predetermined point on patient's the skin or acupuncture point, apply low-current electrical signal for each project in the described reference database.These signals of telecommunication are applied on these aspects, have promptly measured before electromotive force to set up calibration acupuncture point level.Follow acupuncture point level and the comparison of described calibration acupuncture point level for the described measurement of each data point.Big disturbance between these values/described blood glucose level in patients of variation expression.
In others, disclose and be used to measure the in vivo device of material, described device can comprise: processor device; Be used to apply at least two electrode assemblies with acknowledge(ment) signal, be used for determining the impedance measurement device of the impedance between described at least two electrode assemblies; The storage device that is used for the data base of store electrons characteristic signal, wherein each electrical signature signal is corresponding to the varying number of material; And the device that is used for described electrical signature signal is applied to described at least two electrode assemblies.
In conjunction with the accompanying drawings, from following detailed, will more be expressly understood these and other feature and advantage.Notice that accompanying drawing is not intended to represent that the unique formation of the present invention is important.
Description of drawings
Fig. 1 a is the sketch map of explanation one embodiment of the present of invention;
Fig. 1 b is the sketch map that explanation can be used in the impedometer in different embodiments of the invention;
Fig. 1 c is the sketch map that explanation can be used in the reset circuit (resetcircuit) in different embodiments of the invention;
Fig. 2 explanation is used for the in vivo general process of the quantitative information of material of non-invasively measuring;
Fig. 3 a explanation is used for the in vivo detailed process of the quantitative information of material of non-invasively measuring;
Fig. 3 b is the continuation of the process shown in Fig. 3 a;
Fig. 4 a-4b has illustrated the curve chart of the impedance measurement that is used for illustrating that time domain is carried out;
Fig. 5 is the sketch map of explanation an alternative embodiment of the invention;
Fig. 6 a is the perspective view of the portable instrument of explanation performance one or more aspects of the present invention;
Fig. 6 b is the decomposition diagram of the portable instrument shown in Fig. 6 a.
The specific embodiment
Yet, should be appreciated that following disclosing provides many different embodiment, or example, it is used to realize different characteristic of the present invention.Assembly is described below, signal, message, agreement, and the specific example of device are to simplify the disclosure.Certainly, these only are examples and do not lie in the present invention who describes in the restriction claim.Proposed known elements and be not described in detail, this is for the fuzzy the present invention of unnecessary details.For most of parts, omitted obtain complete understanding of the present invention unessential details, its level of detail is in those possessing an ordinary skill in the pertinent arts' the limit of power.Omitted details about control circuit described herein and mechanism; This is because this control circuit is in those possessing an ordinary skill in the pertinent arts' the limit of power.
The acupuncture point is known by the people in Chinese medicine.In twentieth century fifties, ReinhardVoll doctor has studied acupuncture therapy and has recognized that human body has about 2000 acupuncture points on skin, and these acupuncture points are along 20 lines that are called as passages through which vital energy circulates.According to Chinese medicine, passages through which vital energy circulates is that the passage and the energy movement of energy is called as gas (Qi).West research also shows availablely finds the acupuncture point by the mapping skin resistance.Therefore, the acupuncture point is special epidermis anatomical position, and wherein the resistance at the resistance ratio surrounding skin of the skin on the acupuncture point or on the acupuncture point is low, thereby makes the acupuncture point become the conductor of the key of electromagnetic signal in the health.Some researchs have shown that impedance of point is about surrounding skin impedance half (perhaps the electrical conductivity at acupuncture point is the twice height of surrounding skin electrical conductivity).Therefore, just may measure the skin of stream electricity or the impedance or the electrical conductivity in other path, to determine the resonance point of organic self-oscillating frequency at the acupuncture point.In this case, human body becomes the main detector of resonance point, and the electrical conductivity between any two differences of health may be second " detector " of health to the resonance action-reaction simultaneously.
As previously mentioned, in some Therapeutic Method, discordant frequency (for example, the characteristic frequency of some pathogen) can be by filtering and conversion.Use electrode, the frequency that these are transformed and can be fed to patient from the frequency of the harmony of separator.Patient's self electromagnetic field reacts to the treatment signal and makes the pattern of modification enter gauge and separator.Can repeat this process, so the intravital pathological signals of body reduces thereupon and finally is eliminated.Shown that eliminating pathological signals from health has useful therapeutic effect.
One aspect of the present invention is recognized some material, and for example glucose also has special electromagnetic oscillation or frequency.For this application, " material " is a kind of specific object or clear and definite synthetics, for example glucose.The vibration related with predetermined substance can change with the quantity of organic substance in vivo.Therefore, different aspect of the present invention uses electromagnetic oscillation to determine intravital material, for example concentration of blood glucose.
As previously mentioned, every kind of " certainly " hunting of frequency that material also has the magnetic of himself.When the frequency of reactant being incorporated into organism by electrode, the conversion that the frequency of reactant and organic frequency interact and produce Frequency and Amplitude.Can detect and the amplitude of measuring-signal or the response or the variation of " excitation ".Therefore, when comparing (reference point also can be to use the first electrical conductivity/impedance measurement of same reaction thing feature), may determine which signal frequency has produced maximum excitation with reference point.When more a plurality of frequency (each frequency is corresponding to the known substances level), the frequency that produces maximum excitation is the frequency corresponding to levels of substance in the organism.
Therefore, relevant for each reference in the reference database, the low-current electrical signal with characteristic frequency be directed in the organism, and it is applied to acupressure point or any other point on the human body, and electromotive force was measured in the past here.Can repeat this process in the reference database each is relevant, up to finding coupling (for example, producing the signal of maximum excitation).
Forward Fig. 1 a now to, one aspect of the present invention has been described.Aspect this, be useful on and measure the in vivo gauge 10 of levels of substance.Gauge 10 comprises user interface 12.User interface 12 can comprise one or more interfaces, and it can receive input and provide output to user or software agent.The particular aspects of user interface 12 can comprise display, touches quick input screen, enter key, mike and/or speaker (not shown).
In one embodiment, reference database 20 can be with reference to or the related numerical tabular of specified level of the middle material of characteristic frequency and " reactant ".S used in this application, reactant be usually with liquid or solvent material with the formation mixture.Because the biological or chemical activity of reactant can the selective response thing.To explain that as the back reactant can be used to determine the self-oscillating frequency of material.By using the technology of experiment, the form of amount of material can be established and be loaded among the data base 20 in related self-oscillating frequency and the reactant.
Memorizer 18 can be communicated by letter with 22b with pair of electrodes 22a.In certain embodiments, an electrode can be active-anodal (active-positive), and another electrode can be passive-negative pole (passive-negative).To explain that as the back electrode 22a and 22b are applicable to and organic skin interacts and can be used to measure the impedance between 2 on the skin.In certain embodiments, electrode is communicated by letter with impedometer 24, impedometer 24 determine or measurement electrode 22a and 22b between impedance.Impedometer 24 can be communicated by letter with amplifier 26, and it amplifies the signal that sends from impedometer 24.
In exemplary embodiment, amplifier 26 can be communicated by letter with analog-digital converter 28, and it will be digital signal from the analog signal conversion of amplifier.In certain embodiments, digital signal can be sent to processor 14.
Forward Fig. 1 b now to, an embodiment of impedometer 24 has been described.In this embodiment, circuit 39 is determined the relative variation of two impedance between electrodes, and the correspondent voltage of output expression impedance variation.In this embodiment, circuit 39 can comprise that branch is clipped to lead 40a and the 40b of electrode 22a and 22b (Fig. 1).Lead 40a can be connected to the negative pole or the anti-phase input of operational amplifier 42.Anodal or the non--anti-phase input of operational amplifier 42 can be connected to and comprise resistance 44, is total to ground wire 46, Voltage Reference 48, and the partial circuit of resistance 50 (partial circuit).The negative conductor of the positive conductor of Voltage Reference 48 and resistance 50 can be connected to resistance 52.Resistance 52 can be connected to the negative input of lead 40a and operational amplifier 42.
In this exemplary embodiment, lead 40b is connected to the output of operational amplifier 42.Resistance 54 also is connected to lead 40b with lead 40a.The output of operational amplifier 42 is to variable gain amplifier 56 output voltages, and variable gain amplifier 56 is applicable to the signal that receives from processor 14 (Fig. 1).Therefore, circuit 39 is to variable gain amplifier 56 output voltages, and it is corresponding to the variation of impedance between electrodes.Variable gain amplifier 56 amplifies this voltage and amplifying signal is sent to analog-digital converter 58.In this exemplary embodiment, analog-digital converter 58 conversions come from the analogue signal of variable gain amplifier 56, and the digital signal of conversion is sent to processor 14.
Forward Fig. 1 c now to, an aspect of reset circuit 30 has been described.In this exemplary embodiment, general analog switch 60 is arranged, it is applicable to from lead 62 and receives the input command that comes from processor 14 (Fig. 1).Analog switch 60 can also be communicated by letter with 22b (Fig. 1) with electrode 22a with 64b by lead 64a respectively.After the suitable order that receives from processor 14, analog switch 60 is activated, and this " short circuit " any residual charge between the electrode effectively.(not shown) in other embodiments, circuit goes for the polarity of alternating electrode 22a and 22b.
Fig. 2 illustrated and determined in vivo, for example the conventional method 200 of the quantity of predetermined substance in the human body.Process is from step 202 beginning and proceed to step 204, and electrical signature wave or the signal corresponding to a frequency is applied to (for example electrode 22a and the 22b of Fig. 1) on the electrode here, wherein electrode can with organic contact skin.The electrical signature signal that applies is relevant with predetermined material concentration.Aspect some of this method, be stored on traditional storage chip the reference database that is pre-existing in (for example, the data base 20 of Fig. 1), it comprises the relation between " feature " signal frequency (for example 22-24KHz) and the known substances reactant concentration.Therefore, each characteristic frequency among the data base is relevant with the concentration known of organic substance in vivo.
In step 206, measure response or " excitation " to the characteristic signal that applies.In step 208, process determines that whether response is by " increase ".In other words, by this way whether organism response, i.e. the signal of telecommunication that demonstration applies and the positive correlation between the known substances concentration.If determine the response of the electronic characteristic (electrical signature) that applies is increased, then process proceeds to step 210, and the dependency between can producing here is to define the level of material in the body (for example glucose).On the other hand, if there is not the response of increase, then process can turn back to step 204,, in certain embodiments, can apply new electrical signature wave here.
As will be explained below, in certain embodiments, process can apply a plurality of electrical signature signal iteratively, and each signal is corresponding to specific material concentration here.The electrical signature signal (or a plurality of signal) of maximum excitation amount can be determined to cause, and reference database can be visited once more to determine specific levels of substance corresponding to frequency.Therefore, can determine the level of material and show levels of substance by user interface.
As an example, the self-oscillating frequency of the glucose molecule of the variable concentrations in the human blood can with the similar frequency match of the glucose of concentration known in the reference solution.In case frequency match then can easily be determined corresponding glucose level in the blood.
The detailed exemplary embodiment of the conventional method that Fig. 3 a and 3b explanation are shown in Figure 2.Process begins in step 302, in certain embodiments, and from this process of signal enabling of user interface.In others, as the process of programming in advance or the result of timing circuit, process can be started by processor.After startup, process proceeds to step 304 then, measures on the skin resistance between two differences by electrode 22a and 22b here.In certain embodiments, two points can be the acupuncture points of dropping on the different passages through which vital energy circulates.In step 306, process determines whether impedance signal (for example, the voltage of expression impedance) is in the acceptable predetermined limit.For example, if too low, then can adjust amplifier gain from the reading of impedance measurement.If reading is not in the predetermined limit, then in step 308, gain coefficient.In step 310, gain coefficient can be stored in the memorizer to be used for carrying out afterwards the purposes of extra impedance measurement.In step 312, gain coefficient can be used to adjust Amplifier Gain.Then process turns back to step 304, measures impedance once more in step 304.In step 306, process determines whether new impedance signal is in the acceptable predetermined limit.In case determined that this signal is in the acceptable limit, then process proceeds to step 314.
In step 314, be applied on the electrode from first characteristic signal of reference database 20.In certain embodiments, signature waveform is corresponding to known glucose level.In step 316, then carry out a series of measurements of resistance in time domain, it has produced first data set.First data set can be by 402 expressions of the curve on the curve chart shown in Fig. 4 a.In Fig. 4 a, the longitudinal axis is represented response or measured impedance.The transverse axis express time.Therefore, curve 402 expression is owing to apply the impedance response as time passes that characteristic signal produces, and wherein characteristic signal is to be applied in 0 o'clock in the time.In other words, each on curve point expression from apply that characteristic signal begins in special time measured impedance value.
Turn back to Fig. 3,, then, can remove the residual voltage on the electrode as described in reference to figure 1c in step 318.In step 320, apply characteristic signal by electrode once more.This is the signal identical with the signal that applies in step 314.In step 322, carry out another serial impedance bioelectrical measurement in time domain, this produces second data set.Second data set can be by 404 expressions of the curve in the curve chart shown in Fig. 4 b.In certain embodiments,, for example measure quality index if do not satisfy predefined index, can repeating step 314 to 322 to produce extra data set.
In step 324, data set is compared to each other to determine whether to reach convergence.The astringent result can be represented that Fig. 4 c represents to append to the curve 402 on the curve 404 diagrammatically by the curve chart shown in Fig. 4 c.If do not reach convergence, then process is directly to step 328.If reach convergence, then in step 326, proceeded to before 328 in process, process is stored as the candidate data group with feature group (signature set).
In step 328, process has determined whether to apply all characteristic signals among the data base.If no, then process proceeds to step 330 and (Fig. 3 a), wherein removes remaining voltage as described in reference to figure 1c.From step 330, process proceeds to step 332, wherein sets up next characteristic signal among the data base to be applied to electrode.Then process turns back to step 314, here for new characteristic signal repeating step 314 to 328.On the other hand, if in step 328, determine that all characteristic signals have been applied to electrode, then process proceeds to step 334.
In step 334, logic circuit checks that the stored candidate data set is to determine having maximum convergence or the group of " the best " candidate in the stored candidate data set.In step 336, use can respond the frequency that is used to produce best candidate, then can visit reference database with determine corresponding to signal levels of substance.Therefore, levels of substance can be determined and be sent to user interface.Process finishes in step 338.
Forward Fig. 5 now to, be useful on and measure the in vivo optional gauge 500 of levels of substance.Gauge 500 comprises pair of electrodes 502a and 502b.An electrode is active-anodal (active-positive), and another electrode is passive-negative pole (passive-negative).Electrode 502a and 502b are applicable to organic skin and interact, and can measure 2 points on the skin, the electrical conductivity on for example different passages through which vital energy circulates between 2.Electrode is communicated by letter with impedometer 504, the impedance between impedometer 504 measurement electrode 502a and the 502b.Impedometer 504 can be communicated by letter with processor 506.As below explaining the each side of processor 506 control instruments 500 in detail.Processor 506 is communicated by letter with first memory device 508 that is used for reference data stored storehouse 510.In certain embodiments, first memory device can be traditional memory chip.In other embodiments, processor 506 can be communicated by letter with second memory device 507 of the data that are used to store temporary variable and measurement.Second memory device 507 can or be configured in the processor or as external chip.Processor 506 can also be communicated by letter with user interface 509, and it can adopt various embodiments, for example screen and input equipment.
In certain embodiments, processor 506 can also be communicated by letter with digital to analog converter 512, and wherein digital to analog converter 512 is converted to analogue signal with the digital signal of from processor.In certain embodiments, analogue signal can be sent to amplifier 514, and amplifier 514 is applicable to and sends signal to electrode 502a and 502b.Reseting signal generator 516 is also communicated by letter with 502b and is applicable to electrode 502a and transmits a signal to electrode.Reseting signal generator 516 is also communicated by letter with processor 506.In certain embodiments, signal generator 516 is adapted to alternate the polarity of the signal of electrode and amplifier 514.In other embodiments, signal generator can be the reset circuit that is similar to reference to the described reset circuit 30 of figure 1a.
As in reference to the described embodiment of figure 1a, user interface 509 can transmit a signal to processor 106 with start-up course.In response, processor 506 start-up courses, it makes impedometer 504 read impedance between electrode 502a and the 502b.Impedometer 504 amplifies impedance signal, and the digitized impedance signal is also sent it back to processor 506.Processor uses initial impedance readings with gain coefficient, and this gain coefficient can be stored in the memorizer 507 for future use.
Then processor 506 starts the data base's 510 who is stored in memorizer 508 the process that reads.Then coding or the characteristic signal from data base 510 is sent to the digital to analog converter 512 that digital signal is converted to analogue signal.Then analogue signal is sent to amplifier 514, and amplifier 514 amplified analog signals also send to electrode 502a and 502b with this signal.Then the impedance between electrode 502a and the 502b can be read by impedometer 504.Then can define the intravital amount of machine according to being similar to above-mentioned iterative process.
The exemplary embodiment of Fig. 6 a illustrative system 600, system 600 is designed to be worn on people's the wrist.As shown, portable gauge 602 is arranged, it is applicable to and is connected to wrist strap 604a and 604b.Gauge 602 can comprise that earlier in respect of figures 1a is to Fig. 1 c or described all parts of Fig. 5.
Fig. 6 b is the decomposition diagram of the portable instrument 602 shown in Fig. 6 a.In this embodiment, gauge 602 comprises user interface, and user interface comprises touch screen 606 and liquid crystal display (LCD) 608.The input that touch screen 606 is accepted from the user, LCD608 shows information and result.In this exemplary embodiment, the case member 610a and the 610b of each parts of encapsulation arranged, wherein for example aforesaid processor of each parts and memory device.In this embodiment, can be on printed circuit board 612 assembling parts.In this specific example, power supply, for example lithium battery 614 provides the power supply that needs for instrument.Electrode 616a can be positioned at the following of table and be applicable to the back side that contacts human wrist with 616b.In certain embodiments, electrode 616a and 616b are by conductive material, and for example rustless steel is made.In an illustrated embodiment, electrode 616a and 616b can be spaced to aim at the acupuncture point of endocrine or lymphsystem passages through which vital energy circulates.
The aforementioned description of embodiments of the invention is provided for the purpose of illustration and description.It is not exhaustive or is not intended to limit the invention to disclosed strict form.According to many modifications of top instruction and conversion is possible.This means that scope of the present invention is not to be limited by this detailed description, but limit by the claim of enclosing.
For example, in certain embodiments, the method for material in definite live body is arranged, described method comprises: electrical signature signal is applied to described live body, and wherein said electrical signature signal is corresponding to the predetermined quantity of described material; Measure of the response of described live body to the described characteristic signal that applies; And whether the response that determine to increase produce by applying described electronic signal, if then determine the quantity of described in vivo described material from the described predetermined quantity of described material.
The above-mentioned method that is similar to can also be arranged, and it further comprises provides a plurality of electrical signature signal, and each characteristic signal in wherein said a plurality of characteristic signals is corresponding to the different predetermined quantity of described material.
The above-mentioned method that is similar to can also be arranged, and wherein said a plurality of characteristic signals are corresponding to the predetermined quantity of described material, the very big quantity of its scope from the less quantity of described material to described material.
The above-mentioned method that is similar to can also be arranged, wherein repeat the described method of claim 1 for each electrical signature signal in described a plurality of electrical signature signal.
The above-mentioned method that is similar to can also be arranged, and wherein said material is a glucose.
The above-mentioned method that is similar to can also be arranged, and the described response of wherein said measurement comprises on the skin of measuring described live body the described impedance between two differences.
The above-mentioned method that is similar to can also be arranged, the described response of wherein said measurement comprises: As time goes on measure owing to apply a plurality of resistance values that the described characteristic signal corresponding to the predetermined quantity of described material produces, to set up first data set of measured data values; Described electrical signature signal is applied on the described live body again; As time goes on measure owing to applying a plurality of resistance values that described characteristic signal produces, to set up second data set of measured data values.
The above-mentioned method that is similar to can also be arranged, and it further comprises any residual charge between the point of removing on the skin.
The above-mentioned method that is similar to can also be arranged, wherein saidly determine to comprise: determine between described first and second data sets, whether have convergence; If between described first and second data sets, have convergence, then described data set be stored as candidate set.
The above-mentioned method that is similar to can also be arranged, it further comprises: check each stored candidate group determining to have maximum constringent described candidate set, and the quantity of described material is set to corresponding to the described feature with maximum constringent described candidate set.
In another embodiment, can be useful on and measure the in vivo device of material, described device is characterised in that: processor device; Be used to apply at least two electrode assemblies with acknowledge(ment) signal, be used for determining the impedance measurement device of the impedance between described at least two electrode assemblies; The storage device that is used for the data base of store electrons characteristic signal, wherein each electrical signature signal is corresponding to the varying number of material; And the device that is used for described electrical signature signal is applied to described at least two electrode assemblies.
Can also have to be similar to above-mentioned device, it is further characterized in that, is used to amplify the amplifier installation of determining the signal of device from described impedance; And to be used for the analog signal conversion from described amplifier installation be the analog-digital commutator of digital signal.
Can also have to be similar to above-mentioned device, it is further characterized in that, is used to regulate the gain adjustment device of the gain of described amplifying device.
Can also have to be similar to above-mentioned device, it is further characterized in that, is used to store the storage device from the definite gain coefficient of described gain adjustment device.
Can also have to be similar to above-mentioned device, it is further characterized in that, the resetting means of any residual voltage between described at least two electrode assemblies that is used to discharge.
Can also have to be similar to above-mentioned device, it is further characterized in that, is used to hold the canning of the parts of described measuring device, and wherein said canning is applicable to strap means and combines.
Can also have to be similar to above-mentioned device, wherein said strap means is the wrist strap means.
Can also have to be similar to above-mentioned device, wherein said electrode assembly is partly made by rustless steel.
Can have to be similar to above-mentioned device, wherein said material is a glucose.
Can have to be similar to above-mentioned device, it is further characterized in that: the digiverter that is used to change the digital signal that comes from described storage device; And the amplifier installation that is used to amplify the analogue signal that comes from described digiverter.
Claims (20)
1, a kind of definite in vivo method of material, described method comprises:
Electrical signature signal is applied to described live body, and wherein said electrical signature signal is corresponding to the predetermined quantity of described material;
Measure of the response of described live body to the described characteristic signal that applies; And
Whether the response that determine to increase produces by applying described electronic signal, if then determine the quantity of described in vivo described material from the described predetermined quantity of described material.
2, the method for claim 1, it further comprises provides a plurality of electrical signature signal, and each characteristic signal in wherein said a plurality of characteristic signals is corresponding to the different predetermined quantity of described material.
3, method as claimed in claim 2, wherein said a plurality of characteristic signals be corresponding to the predetermined quantity of described material, the big quantity of its scope from the little quantity of described material to described material.
4,, wherein repeat the described method of claim 1 for each electrical signature signal in described a plurality of electrical signature signal as claim 2 or 3 described methods.
5, the method for claim 1, wherein said material is a glucose.
6, the method for claim 1, the described response of wherein said measurement comprise on the skin of measuring described live body the described impedance between two differences.
7, as claim 1 or 4 described methods, the described response of wherein said measurement comprises:
As time goes on measure owing to apply a plurality of resistance values that the described characteristic signal corresponding to the predetermined quantity of described material produces, to set up first data set of measured data values;
Described electrical signature signal is applied on the described live body again;
As time goes on measure owing to applying a plurality of resistance values that described characteristic signal produces, to set up second data set of measured data values.
8, method as claimed in claim 7, it further comprises any residual charge between the point of removing on the skin.
9, method as claimed in claim 7, wherein saidly determine to comprise:
Determine between described first and second data sets, whether have convergence; If between described first and second data sets, have convergence, then described data set be stored as candidate set.
10, method as claimed in claim 9, it further comprises:
Check each stored candidate group determining to have maximum constringent described candidate set, and
The quantity of described material is set to corresponding to the described feature with maximum constringent described candidate set.
11, a kind ofly be used to measure the in vivo device of material, described device is characterised in that:
One processor device;
Be used to apply at least two electrode assemblies with acknowledge(ment) signal,
Be used for determining an impedance measurement device of the impedance between described at least two electrode assemblies;
Be used for the data base's of store electrons characteristic signal a storage device, wherein each electrical signature signal is corresponding to the varying number of material; And
Be used for described electrical signature signal is applied to a device of described at least two electrode assemblies.
12, device as claimed in claim 11, it is further characterized in that:
Be used to amplify a amplifier installation from the signal of described impedance measuring instrument; And
Be used for to be an analog-digital commutator of digital signal from the analog signal conversion of described amplifier installation.
13, device as claimed in claim 11, it is further characterized in that a gain adjustment device of the gain that is used to regulate described amplifying device.
14, device as claimed in claim 13, it is further characterized in that a storage device that is used to store from the definite gain coefficient of described gain adjustment device.
15, device as claimed in claim 11, it is further characterized in that a resetting means of any residual voltage between described at least two electrode assemblies that is used to discharge.
16, device as claimed in claim 11, it is further characterized in that a canning of the parts that are used to hold described measuring device, wherein said canning is applicable to strap means and combines.
17, device as claimed in claim 16, wherein said strap means are the wrist strap means.
18, device as claimed in claim 11, wherein said electrode assembly is partly made by rustless steel.
19, device as claimed in claim 11, wherein said material is a glucose.
20, device as claimed in claim 11, it is further characterized in that:
Be used to change a digiverter of the digital signal that comes from described storage device; And
Be used to amplify an amplifier installation of the analogue signal that comes from described digiverter.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55091304P | 2004-03-06 | 2004-03-06 | |
| US60/550,913 | 2004-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1925786A true CN1925786A (en) | 2007-03-07 |
Family
ID=34976112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2005800069260A Pending CN1925786A (en) | 2004-03-06 | 2005-03-05 | Methods and devices for non-invasively measuring quantitative information of substances in living organisms |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7395104B2 (en) |
| EP (1) | EP1722681A4 (en) |
| JP (1) | JP2007527750A (en) |
| KR (1) | KR20060129507A (en) |
| CN (1) | CN1925786A (en) |
| AU (1) | AU2005220794A1 (en) |
| CA (1) | CA2558239A1 (en) |
| EA (1) | EA200601463A1 (en) |
| IL (1) | IL177889A0 (en) |
| TW (1) | TW200535416A (en) |
| WO (1) | WO2005086725A2 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103892843A (en) * | 2012-12-27 | 2014-07-02 | 龙华科技大学 | Non-intrusive blood glucose measurer |
| TWI450707B (en) * | 2010-11-09 | 2014-09-01 | Univ Chung Hua | Bio-impedance measurement apparatus and assembly |
| CN104545910A (en) * | 2014-12-29 | 2015-04-29 | 深圳市前海安测信息技术有限公司 | Method and system for chronic disease early period electrophysiological detection |
| CN105011946A (en) * | 2015-07-22 | 2015-11-04 | 通普生物科技（北京）有限公司 | Method for measuring value of blood glucose |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6697658B2 (en) | 2001-07-02 | 2004-02-24 | Masimo Corporation | Low power pulse oximeter |
| US6989891B2 (en) | 2001-11-08 | 2006-01-24 | Optiscan Biomedical Corporation | Device and method for in vitro determination of analyte concentrations within body fluids |
| WO2005086725A2 (en) * | 2004-03-06 | 2005-09-22 | Calisto Medical, Inc. | Methods and devices for non-invasively measuring quantitative information of substances in living organisms |
| EP2286721B1 (en) | 2005-03-01 | 2018-10-24 | Masimo Laboratories, Inc. | Physiological Parameter Confidence Measure |
| JP4947440B2 (en) * | 2005-11-10 | 2012-06-06 | バイオボーション・アーゲー | Device for determining glucose levels in body tissue |
| US7937140B2 (en) * | 2006-06-12 | 2011-05-03 | Regni Jr Gerald J | Detection and diagnostic system and method |
| US20080077072A1 (en) * | 2006-08-15 | 2008-03-27 | Richard Keenan | Analyte detection system with user interface providing trend display |
| WO2009091955A1 (en) * | 2008-01-16 | 2009-07-23 | Issa Salim | Systems and methods for therapeutic treatments |
| US8682425B2 (en) * | 2008-01-30 | 2014-03-25 | Miridia Technology Inc. | Electroacupuncture system |
| US20090270756A1 (en) * | 2008-04-23 | 2009-10-29 | Gamache Ronald W | Determining physiological characteristics of animal |
| US8437825B2 (en) | 2008-07-03 | 2013-05-07 | Cercacor Laboratories, Inc. | Contoured protrusion for improving spectroscopic measurement of blood constituents |
| US8515509B2 (en) | 2008-08-04 | 2013-08-20 | Cercacor Laboratories, Inc. | Multi-stream emitter for noninvasive measurement of blood constituents |
| US9307935B2 (en) | 2008-10-27 | 2016-04-12 | Biosensors, Inc. | Non-invasive monitoring of blood metabolite levels |
| US9681820B2 (en) * | 2010-10-21 | 2017-06-20 | Highland Instruments, Inc. | Systems for detecting a condition |
| US10085670B2 (en) * | 2010-11-30 | 2018-10-02 | Newlife Sciences Llc | Apparatus and method for treatment of pain with body impedance analyzer |
| US20130261420A1 (en) * | 2011-06-06 | 2013-10-03 | Semen Kucherov | System and method for non-invasive diagnostic of mammals |
| US8781565B2 (en) | 2011-10-04 | 2014-07-15 | Qualcomm Incorporated | Dynamically configurable biopotential electrode array to collect physiological data |
| US20130317318A1 (en) * | 2012-05-25 | 2013-11-28 | Qualcomm Incorporated | Methods and devices for acquiring electrodermal activity |
| US9378655B2 (en) | 2012-12-03 | 2016-06-28 | Qualcomm Incorporated | Associating user emotion with electronic media |
| US9462949B2 (en) * | 2014-07-31 | 2016-10-11 | Chung Hua University | Method for biomedical system |
| US11471109B2 (en) * | 2015-07-09 | 2022-10-18 | Capsuletech, Inc. | Methods and devices for recovering data from an amplitude-modulated signal |
| US11696715B2 (en) | 2015-07-10 | 2023-07-11 | Bodyport Inc. | Cardiovascular signal acquisition, fusion, and noise mitigation |
| US11197628B2 (en) * | 2015-07-10 | 2021-12-14 | Bodyport Inc. | Cardiovascular health monitoring device |
| MX2021015378A (en) | 2019-06-12 | 2022-01-24 | Truerelief Llc | System and method for delivering pulsed electric current to living tissue. |
| EP3782546B1 (en) * | 2019-08-20 | 2024-02-28 | Rayonex Biomedical GmbH | Method for identifying an acupuncture point and/or a meridian |
| US11324423B2 (en) * | 2019-08-27 | 2022-05-10 | eTouch Medical Inc. | Non-invasive system for testing blood sugar and method of the same |
| CN115066203A (en) | 2020-01-13 | 2022-09-16 | 梅西莫股份有限公司 | Wearable device with physiological parameter monitoring |
| US20210369134A1 (en) * | 2020-06-01 | 2021-12-02 | Wellness Allied Inc | Device and method to measure meridian impedances |
| US11911605B2 (en) | 2021-03-05 | 2024-02-27 | Truerelief Llc | Method and apparatus for injury treatment |
Family Cites Families (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US455271A (en) * | 1891-06-30 | Shingles | ||
| FR1344459A (en) | 1962-10-18 | 1963-11-29 | Method and apparatus for the electrical study of living organisms | |
| US3608543A (en) * | 1968-10-03 | 1971-09-28 | Univ Carnegie Mellon | Physiological impedance-measuring apparatus |
| IL134381A (en) | 2000-02-03 | 2006-06-11 | Alexander Kanevsky | Non-invasive method for disease diagnosis |
| US3971366A (en) * | 1974-11-25 | 1976-07-27 | Hiroshi Motoyama | Apparatus and method for measuring the condition of the meridians and the corresponding internal organs of the living body |
| US4016870A (en) | 1975-10-14 | 1977-04-12 | Chuck Lock | Electronic acupuncture point finder |
| JPS584982B2 (en) | 1978-10-31 | 1983-01-28 | 松下電器産業株式会社 | enzyme electrode |
| US4317817A (en) | 1979-08-27 | 1982-03-02 | Richardson-Merrell Inc. | Novel steroid 5α-reductase inhibitors |
| FR2473882A1 (en) | 1980-01-21 | 1981-07-24 | Deloffre Auguste | APPARATUS FOR DETECTING ACUPUNCTURE POINTS OF A PATIENT AND FOR APPLYING ELECTRICAL STIMULATION SIGNALS TO DETECT POINTS |
| US4494552A (en) * | 1980-08-08 | 1985-01-22 | R2 Corporation | Physiological monitoring electrode system |
| US4436094A (en) | 1981-03-09 | 1984-03-13 | Evreka, Inc. | Monitor for continuous in vivo measurement of glucose concentration |
| US4431004A (en) | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| CA1196691A (en) * | 1982-01-12 | 1985-11-12 | Bradley Fry | Reconstruction system and methods for impedance imaging |
| US4557271A (en) | 1983-05-11 | 1985-12-10 | Stoller Kenneth P | Method and apparatus for detecting body illness, dysfunction, disease and/or pathology |
| US5197951A (en) | 1983-12-14 | 1993-03-30 | Mahurkar Sakharam D | Simple double lumen catheter |
| US4655225A (en) | 1985-04-18 | 1987-04-07 | Kurabo Industries Ltd. | Spectrophotometric method and apparatus for the non-invasive |
| US4690152A (en) * | 1985-10-23 | 1987-09-01 | American Mediscan, Inc. | Apparatus for epithelial tissue impedance measurements |
| US4714080A (en) | 1986-10-06 | 1987-12-22 | Nippon Colin Co., Ltd. | Method and apparatus for noninvasive monitoring of arterial blood oxygen saturation |
| US5163439A (en) | 1986-11-05 | 1992-11-17 | Dardik Irving I | Rhythmic biofeedback technique |
| US4897162A (en) | 1986-11-14 | 1990-01-30 | The Cleveland Clinic Foundation | Pulse voltammetry |
| US4911175A (en) | 1987-09-17 | 1990-03-27 | Diana Twyman | Method for measuring total body cell mass and total extracellular mass by bioelectrical resistance and reactance |
| JPH0827235B2 (en) | 1987-11-17 | 1996-03-21 | 倉敷紡績株式会社 | Spectroscopic method for measuring sugar concentration |
| US4882492A (en) | 1988-01-19 | 1989-11-21 | Biotronics Associates, Inc. | Non-invasive near infrared measurement of blood analyte concentrations |
| US4947862A (en) | 1988-10-28 | 1990-08-14 | Danninger Medical Technology, Inc. | Body composition analyzer |
| US5028787A (en) | 1989-01-19 | 1991-07-02 | Futrex, Inc. | Non-invasive measurement of blood glucose |
| US5086229A (en) | 1989-01-19 | 1992-02-04 | Futrex, Inc. | Non-invasive measurement of blood glucose |
| US5077476A (en) | 1990-06-27 | 1991-12-31 | Futrex, Inc. | Instrument for non-invasive measurement of blood glucose |
| US5139023A (en) | 1989-06-02 | 1992-08-18 | Theratech Inc. | Apparatus and method for noninvasive blood glucose monitoring |
| US5101814A (en) | 1989-08-11 | 1992-04-07 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
| US5846189A (en) * | 1989-09-08 | 1998-12-08 | Pincus; Steven M. | System for quantifying asynchrony between signals |
| US5769793A (en) * | 1989-09-08 | 1998-06-23 | Steven M. Pincus | System to determine a relative amount of patternness |
| US5562596A (en) * | 1989-09-08 | 1996-10-08 | Steven M. Pincus | Method and apparatus for controlling the flow of a medium |
| US5050612A (en) | 1989-09-12 | 1991-09-24 | Matsumura Kenneth N | Device for computer-assisted monitoring of the body |
| CA2028261C (en) | 1989-10-28 | 1995-01-17 | Won Suck Yang | Non-invasive method and apparatus for measuring blood glucose concentration |
| US5036861A (en) | 1990-01-11 | 1991-08-06 | Sembrowich Walter L | Method and apparatus for non-invasively monitoring plasma glucose levels |
| US5070874A (en) | 1990-01-30 | 1991-12-10 | Biocontrol Technology, Inc. | Non-invasive determination of glucose concentration in body of patients |
| US5222496A (en) | 1990-02-02 | 1993-06-29 | Angiomedics Ii, Inc. | Infrared glucose sensor |
| US5222495A (en) | 1990-02-02 | 1993-06-29 | Angiomedics Ii, Inc. | Non-invasive blood analysis by near infrared absorption measurements using two closely spaced wavelengths |
| US5115133A (en) | 1990-04-19 | 1992-05-19 | Inomet, Inc. | Testing of body fluid constituents through measuring light reflected from tympanic membrane |
| US5079421A (en) | 1990-04-19 | 1992-01-07 | Inomet, Inc. | Invasive FTIR blood constituent testing |
| EP0465897B1 (en) | 1990-07-09 | 1997-09-10 | Fuji Photo Film Co., Ltd. | A lens-fitted main body of a camera |
| US5131401A (en) | 1990-09-10 | 1992-07-21 | Axon Medical Inc. | Method and apparatus for monitoring neuromuscular blockage |
| US5063937A (en) | 1990-09-12 | 1991-11-12 | Wright State University | Multiple frequency bio-impedance measurement system |
| AU658177B2 (en) * | 1991-03-07 | 1995-04-06 | Masimo Corporation | Signal processing apparatus and method |
| US5322063A (en) | 1991-10-04 | 1994-06-21 | Eli Lilly And Company | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
| US5372141A (en) | 1992-07-01 | 1994-12-13 | Body Composition Analyzers, Inc. | Body composition analyzer |
| US5433197A (en) | 1992-09-04 | 1995-07-18 | Stark; Edward W. | Non-invasive glucose measurement method and apparatus |
| US5360004A (en) | 1992-12-09 | 1994-11-01 | Diasense, Inc. | Non-invasive determination of analyte concentration using non-continuous radiation |
| US5379764A (en) | 1992-12-09 | 1995-01-10 | Diasense, Inc. | Non-invasive determination of analyte concentration in body of mammals |
| US5339827A (en) | 1993-02-11 | 1994-08-23 | Intech Scientific, Inc. | Acupuncture system and method |
| US5579782A (en) | 1993-08-12 | 1996-12-03 | Omron Corporation | Device to provide data as a guide to health management |
| US5568049A (en) | 1993-10-22 | 1996-10-22 | The United States Of America As Represented By The Secretary Of The Navy | Fiber optic faraday flux transformer sensor and system |
| US5458140A (en) * | 1993-11-15 | 1995-10-17 | Non-Invasive Monitoring Company (Nimco) | Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
| US5590650A (en) | 1994-11-16 | 1997-01-07 | Raven, Inc. | Non-invasive medical monitor system |
| AT130U3 (en) | 1994-11-23 | 1995-07-25 | 5E Systeme Fuer Holistische Me | DEVICE AND METHOD FOR RECORDING SUBDEVICE AND METHOD FOR RECORDING SUBSTANCE SPECIFIC AND BODY SPECIFIC ENERGY DANCE SPECIFIC AND BODY SPECIFIC ENERGETIC INFORMATION |
| JP3240401B2 (en) | 1994-12-07 | 2001-12-17 | オムロン株式会社 | Impedance measurement device and health management guideline advice device |
| US5752512A (en) * | 1995-05-10 | 1998-05-19 | Massachusetts Institute Of Technology | Apparatus and method for non-invasive blood analyte measurement |
| US6456865B2 (en) | 1995-06-08 | 2002-09-24 | Ilan Zadik Samson | Non-invasive medical probe |
| KR0161602B1 (en) | 1995-06-24 | 1999-01-15 | 이재석 | Component analysis of human body and analytical method thereof using bioelectrical impedance analysis |
| US7016713B2 (en) | 1995-08-09 | 2006-03-21 | Inlight Solutions, Inc. | Non-invasive determination of direction and rate of change of an analyte |
| US5725480A (en) | 1996-03-06 | 1998-03-10 | Abbott Laboratories | Non-invasive calibration and categorization of individuals for subsequent non-invasive detection of biological compounds |
| US6990422B2 (en) | 1996-03-27 | 2006-01-24 | World Energy Labs (2), Inc. | Method of analyzing the time-varying electrical response of a stimulated target substance |
| US6016445A (en) | 1996-04-16 | 2000-01-18 | Cardiotronics | Method and apparatus for electrode and transthoracic impedance estimation |
| US6517482B1 (en) | 1996-04-23 | 2003-02-11 | Dermal Therapy (Barbados) Inc. | Method and apparatus for non-invasive determination of glucose in body fluids |
| US5890489A (en) | 1996-04-23 | 1999-04-06 | Dermal Therapy (Barbados) Inc. | Method for non-invasive determination of glucose in body fluids |
| US6120460A (en) | 1996-09-04 | 2000-09-19 | Abreu; Marcio Marc | Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions |
| US6544193B2 (en) | 1996-09-04 | 2003-04-08 | Marcio Marc Abreu | Noninvasive measurement of chemical substances |
| US5830139A (en) * | 1996-09-04 | 1998-11-03 | Abreu; Marcio M. | Tonometer system for measuring intraocular pressure by applanation and/or indentation |
| US5894939A (en) | 1996-10-09 | 1999-04-20 | Frankel Industries, Inc. | System for sorting post-consumer plastic containers for recycling |
| US6246893B1 (en) | 1997-06-12 | 2001-06-12 | Tecmed Incorporated | Method and device for glucose concentration measurement with special attention to blood glucose determinations |
| US7039446B2 (en) | 2001-01-26 | 2006-05-02 | Sensys Medical, Inc. | Indirect measurement of tissue analytes through tissue properties |
| AU1401599A (en) | 1997-11-12 | 1999-05-31 | Lightouch Medical, Inc. | Method for non-invasive measurement of an analyte |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US6558320B1 (en) | 2000-01-20 | 2003-05-06 | Medtronic Minimed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
| US6261236B1 (en) | 1998-10-26 | 2001-07-17 | Valentin Grimblatov | Bioresonance feedback method and apparatus |
| US6266774B1 (en) | 1998-12-08 | 2001-07-24 | Mcafee.Com Corporation | Method and system for securing, managing or optimizing a personal computer |
| US6280381B1 (en) | 1999-07-22 | 2001-08-28 | Instrumentation Metrics, Inc. | Intelligent system for noninvasive blood analyte prediction |
| US6424847B1 (en) * | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
| DE19911200A1 (en) * | 1999-03-13 | 2000-09-21 | Bruno M Hess | Device for measurement of bio-electric parameters such as voltage and resistance of skin or tissue between acupuncture points in a human or animal has opposite polarity constant current sources and measurement electrodes |
| AUPQ113799A0 (en) | 1999-06-22 | 1999-07-15 | University Of Queensland, The | A method and device for measuring lymphoedema |
| KR100324703B1 (en) | 1999-08-09 | 2002-02-16 | 차기철 | Apparatus and Method for Analyzing Body Composition Using Novel Hand Electrodes |
| DE60037764T2 (en) | 1999-10-12 | 2009-01-08 | Tanita Corp. | Measuring device for a living body |
| US6594521B2 (en) | 1999-12-17 | 2003-07-15 | Electrical Geodesics, Inc. | Method for localizing electrical activity in the body |
| US6702743B2 (en) | 2000-05-26 | 2004-03-09 | Inta-Medics, Ltd. | Ultrasound apparatus and method for tissue resonance analysis |
| US6328694B1 (en) | 2000-05-26 | 2001-12-11 | Inta-Medics, Ltd | Ultrasound apparatus and method for tissue resonance analysis |
| US6522903B1 (en) | 2000-10-19 | 2003-02-18 | Medoptix, Inc. | Glucose measurement utilizing non-invasive assessment methods |
| JP2004522500A (en) | 2001-01-22 | 2004-07-29 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | Lancet device with capillary action |
| US6841389B2 (en) | 2001-02-05 | 2005-01-11 | Glucosens, Inc. | Method of determining concentration of glucose in blood |
| JP3562798B2 (en) | 2001-03-01 | 2004-09-08 | 学校法人慶應義塾 | Method and apparatus for analyzing biological reaction waveform information and diagnostic apparatus |
| RU2179042C1 (en) | 2001-03-23 | 2002-02-10 | Маркин Юрий Владимирович | Method and device for treating human organism |
| CA2449567A1 (en) | 2001-06-13 | 2002-12-19 | Ckm Diagnostics, Inc. | Non-invasive method and apparatus for tissue detection |
| US6599253B1 (en) | 2001-06-25 | 2003-07-29 | Oak Crest Institute Of Science | Non-invasive, miniature, breath monitoring apparatus |
| US6631282B2 (en) | 2001-08-09 | 2003-10-07 | Optiscan Biomedical Corporation | Device for isolating regions of living tissue |
| JP2005500116A (en) | 2001-08-24 | 2005-01-06 | グルコセンス、インコーポレイテッド | Biosignal sensor and apparatus for recording a biosignal incorporating an application associated with the sensor |
| JPWO2003062214A1 (en) | 2002-01-23 | 2005-05-19 | 杏林製薬株式会社 | Novel stable crystals of benzylthiazolidinedione derivatives and their preparation |
| US7050847B2 (en) | 2002-03-26 | 2006-05-23 | Stig Ollmar | Non-invasive in vivo determination of body fluid parameter |
| US7027848B2 (en) | 2002-04-04 | 2006-04-11 | Inlight Solutions, Inc. | Apparatus and method for non-invasive spectroscopic measurement of analytes in tissue using a matched reference analyte |
| CN1655815A (en) | 2002-05-20 | 2005-08-17 | 切姆斯托普有限公司 | Process for the preparation and activation of substances and a means of producing same |
| JP2004016609A (en) | 2002-06-19 | 2004-01-22 | Omron Healthcare Co Ltd | Method and apparatus for measuring concentration of bodily fluid component |
| US6865407B2 (en) | 2002-07-11 | 2005-03-08 | Optical Sensors, Inc. | Calibration technique for non-invasive medical devices |
| JP4975249B2 (en) | 2002-10-09 | 2012-07-11 | ボディーメディア インコーポレイテッド | Device for measuring an individual's state parameters using physiological information and / or context parameters |
| JP2004329412A (en) * | 2003-05-02 | 2004-11-25 | Tanita Corp | Body composition measuring instrument |
| US6954662B2 (en) | 2003-08-19 | 2005-10-11 | A.D. Integrity Applications, Ltd. | Method of monitoring glucose level |
| WO2005086725A2 (en) * | 2004-03-06 | 2005-09-22 | Calisto Medical, Inc. | Methods and devices for non-invasively measuring quantitative information of substances in living organisms |
-
2005
- 2005-03-05 WO PCT/US2005/007207 patent/WO2005086725A2/en active Application Filing
- 2005-03-05 JP JP2007502045A patent/JP2007527750A/en active Pending
- 2005-03-05 KR KR1020067019864A patent/KR20060129507A/en not_active Application Discontinuation
- 2005-03-05 CA CA002558239A patent/CA2558239A1/en not_active Abandoned
- 2005-03-05 EP EP05747040A patent/EP1722681A4/en not_active Withdrawn
- 2005-03-05 EA EA200601463A patent/EA200601463A1/en unknown
- 2005-03-05 CN CNA2005800069260A patent/CN1925786A/en active Pending
- 2005-03-05 AU AU2005220794A patent/AU2005220794A1/en not_active Abandoned
- 2005-03-06 US US11/074,283 patent/US7395104B2/en not_active Expired - Fee Related
- 2005-03-07 TW TW094106834A patent/TW200535416A/en unknown
-
2006
- 2006-09-04 IL IL177889A patent/IL177889A0/en unknown
-
2007
- 2007-03-01 US US11/680,907 patent/US20070156040A1/en not_active Abandoned
- 2007-03-01 US US11/680,927 patent/US20070149876A1/en not_active Abandoned
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI450707B (en) * | 2010-11-09 | 2014-09-01 | Univ Chung Hua | Bio-impedance measurement apparatus and assembly |
| US8825150B2 (en) | 2010-11-09 | 2014-09-02 | Chung Hua University | Bio-impedance measurement apparatus and assembly |
| CN103892843A (en) * | 2012-12-27 | 2014-07-02 | 龙华科技大学 | Non-intrusive blood glucose measurer |
| CN104545910A (en) * | 2014-12-29 | 2015-04-29 | 深圳市前海安测信息技术有限公司 | Method and system for chronic disease early period electrophysiological detection |
| CN104545910B (en) * | 2014-12-29 | 2017-08-22 | 深圳市前海安测信息技术有限公司 | Chronic disease early stage electro physiology detection method and system |
| CN105011946A (en) * | 2015-07-22 | 2015-11-04 | 通普生物科技（北京）有限公司 | Method for measuring value of blood glucose |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005086725A2 (en) | 2005-09-22 |
| EP1722681A4 (en) | 2010-03-03 |
| US20070156040A1 (en) | 2007-07-05 |
| IL177889A0 (en) | 2006-12-31 |
| CA2558239A1 (en) | 2005-09-22 |
| WO2005086725A3 (en) | 2006-08-03 |
| US20070149876A1 (en) | 2007-06-28 |
| US7395104B2 (en) | 2008-07-01 |
| EA200601463A1 (en) | 2007-02-27 |
| JP2007527750A (en) | 2007-10-04 |
| KR20060129507A (en) | 2006-12-15 |
| US20050197555A1 (en) | 2005-09-08 |
| EP1722681A2 (en) | 2006-11-22 |
| TW200535416A (en) | 2005-11-01 |
| AU2005220794A1 (en) | 2005-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1925786A (en) | Methods and devices for non-invasively measuring quantitative information of substances in living organisms | |
| US20220062642A1 (en) | Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters | |
| US20160256693A1 (en) | Systems, devices, and methods for electrical stimulation using a chemical biomarker for feedback to adjust stimulation parameters | |
| US20040087838A1 (en) | Meridian linking diagnostic and treatment system and method for treatment of manifested and latent maladies using the same | |
| CN101998840A (en) | Method and device for non-invasive determination of the concentration of a substance in a body fluid | |
| Nam et al. | Next-generation wearable biosensors developed with flexible bio-chips | |
| AU2002312721B2 (en) | Method and device for detecting functional and metabolic data of a living organism | |
| Dolbow et al. | Invasive and non-invasive approaches of electrical stimulation to improve physical functioning after spinal cord injury | |
| Stradolini et al. | Simultaneous monitoring of anesthetics and therapeutic compounds with a portable multichannel potentiostat | |
| CN208302083U (en) | A kind of pelvic diaphragm muscle instrument for training | |
| Iniewski | CMOS Biomicrosystems: Where Electronics Meet Biology | |
| Cariappa | Fabrication and characterization of spinal stimulation electrodes | |
| Cömert | The Assessment and Reduction of Motion Artifact in Dry Contact Biopotential Electrodes | |
| KR101022338B1 (en) | Method of checking energy balance by measuring energy of outer skin | |
| Mutai et al. | Design and Implementation of Remote Surface Electromyography Monitoring System for Patients with Muscle Disorders | |
| Acharya et al. | Comparison of walking parameters obtained from the young, elderly and adults with support | |
| Covey et al. | Technological evolution of wireless neurochemical sensing with fast-scan cyclic voltammetry | |
| Imani | Low Power Analog Techniques for Wearable Biosensors | |
| MXPA06010171A (en) | Methods and devices for non-invasively measuring quantitative information of substances in living organisms | |
| Aamir | 2018 Index IEEE Transactions on Biomedical Circuits and Systems Vol. 12 | |
| Chen et al. | A Novel EMG Feedback Control Method in Functional Electrical Stimulation Cycling System for Stroke Patients | |
| JP2004290523A (en) | Endermatic analyte measuring system and endermatic analyte measuring method | |
| CN2426336Y (en) | Gastric dynamics tester | |
| Esser | Design and development of an electronic system for the selective stimulation and simultaneous measurement of the skin impedance | |
| JP2006034210A (en) | Method for measuring intracorpoleal information of mouse or rat body and mouse or rat of which intracorpoleal information can be measured |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |